Feasibility and efficacy of argon plasma coagulation for early esophageal squamous cell neoplasia^[*]

We present 19 cases in which argon plasma coagulation (APC) was used as curative initial treatment for 5 low-grade esophageal squamous intraepithelial neoplasias (ESINs), 12 high-grade ESINs, and 2 early esophageal squamous cell carcinomas (ESCCs). Complete response was defined as the absence of tumor from any biopsy taken from the ablated lesion. At follow-up endoscopy 2 – 4 months after APC, 94.7 % of patients had achieved complete response in a single treatment session. Only one patient with high-grade ESIN showed local recurrence. This patient underwent additional APC and showed complete response at 12 months after initial APC. At the 12-month follow-up endoscopy, again 94.7 % had a complete response. The exception was one patient with local recurrence, who underwent additional APC. After the 12-month follow-up endoscopy, no patient showed local recurrence during a median follow-up of 22 months. No stricture requiring endoscopic dilation occurred after the procedure. This study suggests that APC is a feasible and effective treatment modality for ESIN and early ESCC.

^* The first two authors (Byung-Hoon Min and Eun Ran Kim) contributed equally to this work.

• References

• 1 Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007; 25: 4110-4117
• 2 Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8: 545-553
• 3 Shimizu M, Nagata K, Yamaguchi H et al. Squamous intraepithelial neoplasia of the esophagus: past, present, and future. J Gastroenterol 2009; 44: 103-112
• 4 Araki K, Ohno S, Egashira A et al. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002; 94: 570-575
• 5 Choi JY, Park YS, Jung HY et al. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 2011; 73: 881-889 , 889 e881-882
• 6 Kim DU, Lee JH, Min BH et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2008; 23: 619-625
• 7 Birkmeyer JD, Siewers AE, Finlayson EV et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
• 8 Chang AC, Ji H, Birkmeyer NJ et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008; 85: 424-429
• 9 Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288
• 10 Bergman JJ, Zhang YM, He S et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc 2011; 74: 1181-1190
• 11 van Vilsteren FG, Alvarez Herrero L, Pouw RE et al. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma. Endoscopy 2011; 43: 282-290
• 12 Zhang YM, Bergman JJ, Weusten B et al. Radiofrequency ablation for early esophageal squamous cell neoplasia. Endoscopy 2010; 42: 327-333
• 13 Dumot JA, Greenwald BD. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC’s of ablative techniques. Endoscopy 2008; 40: 1026-1032
• 14 Muguruma N, Okamoto K, Kimura T et al. Endoscopic ablation therapy for gastrointestinal superficial neoplasia. Dig Endosc 2012; 24: 139-149
• 15 Nomura T, Miyashita M, Makino H et al. Argon plasma coagulation for the treatment of superficial esophageal carcinoma. J Nihon Med Sch 2007; 74: 163-167
• 16 Pech O, May A, Rabenstein T et al. Endoscopic resection of early oesophageal cancer. Gut 2007; 56: 1625-1634
• 17 Eickhoff A, Jakobs R, Schilling D et al. Prospective nonrandomized comparison of two modes of argon beamer (APC) tumor desobstruction: effectiveness of the new pulsed APC versus forced APC. Endoscopy 2007; 39: 637-642
• 18 Manner H, May A, Faerber M et al. The tissue effect of second generation argon plasma coagulation (VIO APC) in comparison to standard APC and Nd:YAG laser in vitro. Acta Gastroenterol Belg 2007; 70: 352-356